Análise provisória | Sabizabulina oral para adultos de alto risco internados com Covid-19.
11 Jul, 2022 | 13:59hOral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis – NEJM Evidence
Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis – NEJM Evidence